EMD Serono Canada Inc.
EMD Serono Canada is the Canadian affiliate of Merck Serono S.A., an affiliate of Merck KGaA, Darmstadt, Germany. Merck Serono S.A is a global biotechnology leader headquartered in Geneva, Switzerland. EMD Serono Canada is an integral part of driving the growth and success of the company’s global business. EMD Serono Canada focuses on specialized therapeutic areas, including reproductive health, neurology, metabolic endocrinology and dermatology. Merck Serono currently operates in 44 countries, with production facilities in eight countries and sales in over 90 countries. The EMD Serono Canada head office is located in Mississauga, Ontario.

Committed to Dermatology
In Canada, we market RAPTIVA® (efalizumab), a selective immunomodulating agent for the treatment of adult patients with moderate to severe chronic plaque psoriasis. We are actively committed to dermatology in Canada:

  • Sponsor of Dermatology Update, the CDA Annual Conference, the DRIVE Program for residents, Psoriasis REVIEW and the Psoriasis Education Program™ (PEP) for patients
  • Proud supporter of the CDA Foundation Research Grant Awards Program
  • Supportive of local R&D with the inclusion of many Canadian research sites in our clinical programs

Our Future
We will continue to grow our current therapeutic areas and enter into new ones, including oncology and additional autoimmune diseases, by developing both bio-therapeutic proteins and small molecules. Merck Serono has an integrated R&D capability in-house, employs over 1,300 R&D personnel, and has a network of biotech alliances with smaller biotech companies and academic groups. We currently have more than 25 ongoing preclinical and clinical development projects.

Merck Serono is committed to discovering and developing medicines that address significant unmet medical needs. We have built a reputation as a leader in the industry by integrating cutting-edge science with comprehensive patient support systems to help improve people’s lives.

 

Click here to close this window
and return to the Dermatology Update Sponsors Page.